LOADING
Comparing Exxon Mobil Corporation (XOM) and Pfizer Inc (PFE) across the Energy and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | XOM | PFE |
|---|---|---|
| Price | $156.97 | $24.91 |
| Change Today | +0.14% | -0.95% |
| Market Cap | $634.3B | $143.3B |
| P/E Ratio | 25.8 | 19.2 |
| Forward P/E | 13.9 | 8.6 |
| PEG Ratio | 1.30 | 2.97 |
| EPS | $6.08 | $1.31 |
| Revenue Growth (YoY) | 2.6% | 5.4% |
| Profit Margin | 7.8% | 11.8% |
| Return on Equity | 9.9% | 8.3% |
| Dividend Yield | 2.64% | 6.81% |
| Beta | 0.16 | 0.31 |
| 52-Week High | $175.22 | $27.80 |
| 52-Week Low | $102.27 | $21.60 |
| Volume | 12.6M | 45.0M |
Exxon Mobil Corporation is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Pfizer Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.